Apeloa Pharmaceutical Co.,Ltd

符号: 000739.SZ

SHZ

14.01

CNY

今天的市场价格

15.0522
市盈率
0.3216
PEG比率
16.38B
MRK市值
0.02%
DIV收益率

Apeloa Pharmaceutical Co.,Ltd (000739-SZ) 财务报表

Q: 什么是 Apeloa Pharmaceutical Co.,Ltd (000739.SZ) 总资产是多少？

Apeloa Pharmaceutical Co.,Ltd (000739.SZ) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Apeloa Pharmaceutical Co.,Ltd (000739.SZ). 的默认数据。公司收入显示 3072.75 M 的平均值，即 0.225 % 增长率。整个期间的平均毛利润为 793.225 M，即 0.491 %. 平均毛利率为 0.211 %. 公司去年的净收入增长率为 0.067 %，等于 0.341 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Apeloa Pharmaceutical Co.,Ltd 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.063. 在流动资产领域，000739.SZ 的报告货币为8368.16. 这些资产中的很大一部分，即 3580.687 是现金和短期投资。与去年的数据相比，该部分的变化率为0.008%. 公司的长期投资虽然不是其重点，但以报告货币计算的174.047（如果有的话）为174.047。这表明与上一报告期相比，90.595% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 18.694. 这一数字表明，3.093% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 6222.729. 这方面的年同比变化率为 0.129%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为2420.562，存货估值为 2083.3，商誉估值为 20.31（如有. 无形资产总额（如果有）按 319.8 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	14812.83	3580.7	3552.9	2624.9	2310.4	1499.7	644	551.2	553	795.1	809.6	812.7	833.4	253.8	279.5	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1	7.8	5	5.5	5.9
balance-sheet.row.short-term-investments	-65.1	0	0.1	14.9	116.2	463.9	-7.2	4.2	-3.7	-4.1	1.9	2	1.9	1.7	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	10834.01	2420.6	2286.8	1804.6	1455	1377.5	1367.7	1488.4	1301.7	863.2	882	979.4	779.4	316.3	267	297.6	223.5	232.5	228.9	200.7	170.3	164.2	129.3	96.7	10.6	5.1	3.8	4.9	14.9	8.2	13.4
balance-sheet.row.inventory	7885.31	2083.3	1801.8	1249.9	1086.2	993	901	727.2	693.5	722.3	585.1	632.3	477.7	301.9	259.3	220.1	257.7	195.7	180.6	165.6	158.5	126.4	119.2	63.1	99.7	106.4	121.3	30	27.3	22.4	42.3
balance-sheet.row.other-current-assets	546.48	283.6	139.6	102.5	65.7	87.7	161.8	103.5	93.6	85.2	58.5	-40.1	-18.2	-2.8	-2.8	-9.6	-5.2	-4.8	-3.4	-5.4	-8.7	-9	-16	-14.8	70.3	80.2	67	26.8	-2.8	4.2	7.1
balance-sheet.row.total-current-assets	34078.64	8368.2	7781.1	5781.9	4917.4	3958	3074.5	2870.2	2641.8	2465.8	2335.2	2384.4	2072.2	869.1	803.1	756.5	756.1	925.8	653.9	498.8	540.7	413.2	262.9	162.4	194.2	265.1	215.1	69.6	44.5	40.3	68.6
balance-sheet.row.property-plant-equipment-net	14152.56	3617.4	3405.9	2682.9	1981.2	2017.8	2123.3	2286.8	2340.2	2306	2139.4	1758.9	1555.1	907	816.9	765.5	749.7	553.5	603.9	609.6	533	347.7	324.4	317.5	243.4	240.6	242.7	234.4	119.9	106	72.8
balance-sheet.row.goodwill	81.24	20.3	20.3	20.3	20.3	20.3	29.5	29.5	29.5	29.5	29.5	20.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1284.29	319.8	378.8	407.6	345.1	331.2	363.2	401.2	441.9	474.5	478.8	470.3	431.5	275.1	217.7	222.9	230.5	131.4	3.4	5.6	8	10.4	2.7	2.2	7.6	8.1	1.9	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	1365.53	340.1	399.1	427.9	365.4	351.5	392.7	430.7	471.4	504	508.3	490.6	451.8	275.1	217.7	222.9	230.5	131.4	3.4	5.6	8	10.4	2.7	2.2	7.6	8.1	1.9	0	0	0	0
balance-sheet.row.long-term-investments	715.76	174	91.3	66.4	5.5	-341.6	108.1	31.8	35.7	33.7	-1.4	-1.5	-1.4	-1.2	-1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	955.25	247.4	265.6	47.6	39.6	49	40.7	55.4	67	59.4	41.2	27.7	27.3	9.9	6.4	4.8	4.8	3.5	3.6	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	270.73	20.6	73.6	156.6	185.6	487.9	11.4	16.2	62.9	26.1	39.1	2.2	2.1	1.7	2.3	0	0	0	19.7	30.9	32.7	91.9	99.2	105.3	101.4	6.6	15.4	13.3	0	0	0.1
balance-sheet.row.total-non-current-assets	17459.84	4399.5	4235.5	3381.4	2577.4	2564.6	2676.2	2820.9	2977.2	2929.2	2726.6	2277.9	2035	1192.6	1041.5	993.2	985	688.4	630.6	646	573.7	449.9	426.4	425	352.4	255.3	260.1	247.7	119.9	106	72.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	51538.48	12767.7	12016.6	9163.3	7494.8	6522.6	5750.8	5691.1	5619	5394.9	5061.8	4662.3	4107.2	2061.8	1844.6	1749.7	1741.1	1614.1	1284.4	1144.9	1114.5	863.1	689.3	587.4	546.6	520.3	475.2	317.2	164.4	146.3	141.5
balance-sheet.row.account-payables	15550.44	2013.9	4310.6	2622.5	1928.7	2010.3	1113.3	933.9	1151.9	1333	1339.6	1109.7	1168.2	510.2	405	407.9	335.2	322.5	225.2	158	174.2	130.6	77.1	70.7	36.7	40.2	39.3	32.6	48.8	38.4	29.6
balance-sheet.row.short-term-debt	5990.9	3403.5	571.9	346.4	330.3	50	614.1	1088	1116.1	1033.1	758.8	1205.9	1242.6	551.5	495.7	420.2	470.2	369.2	383.1	333.2	352.2	203.2	264.7	154.2	117	86	34	20	6	18.2	21.1
balance-sheet.row.tax-payables	383.56	77	117.6	190.7	227.7	83.3	87.3	101	99.6	64.5	71.7	47	57.1	14.3	8.4	10.5	8.1	7.6	16.5	10.4	5.5	9.4	7	6.9	2.5	5.1	13.2	5.2	7.1	10	3.4
balance-sheet.row.long-term-debt-total	267.11	18.7	265.4	127.9	0	72	72	72	180	196.6	172	167	37.5	38.5	0	0	60	90	130	140	140	110	0	40	0	0	0	0	30	17.2	34.3
Deferred Revenue Non Current	132.38	30.6	15.1	119.8	125.4	119.8	130.1	129.8	100.9	98.7	95.4	83.6	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	418.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1435.26	460	685.9	18	5.8	140.5	388.9	75.1	77.3	53.6	70.8	80.7	34.9	27	17.6	13.6	29.4	28.2	22.6	15.9	9.8	6.1	5.2	3.7	54.3	58.5	77.2	1.2	0.5	0.5	0.2
balance-sheet.row.total-non-current-liabilities	1079.97	198.9	470.8	324	207.7	193	202.8	203.7	353.7	296.3	268.4	242.8	111.5	76.4	16.4	18.7	65.4	93.8	130	140	145.4	122.3	0	40	3.6	3.2	2.3	1.4	30.6	17.5	34.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	32.69	4.5	15.8	22.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	27012.14	6506.6	6497.4	4103.3	3104.1	2754.6	2406.5	2641.1	3002.5	2978.1	2755.9	2804.4	2741.6	1255.1	1036	954.9	973	864	828.7	732.9	743.4	534.2	402.9	327.7	231.5	212.4	227.2	95.8	114.2	98.5	106.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	4714.09	1178.5	1178.5	1178.5	1178.5	1178.5	1178.5	1178.5	1146.9	1146.9	1146.9	815.5	374.5	256.7	256.7	256.7	256.7	256.7	145.7	145.7	145.7	145.7	145.7	145.7	145.7	145.7	75.6	63	32.6	18.4	18.4
balance-sheet.row.retained-earnings	17750.62	4520	3854.5	3240.1	2608.8	2018.8	1619.6	1340.1	1172.9	981.8	876.8	575.1	408.9	164.4	161.3	143.2	114.5	86.8	111.4	76.9	54.8	37.2	14.2	-66.4	-5.3	-10.9	20.6	0.7	0	15.5	5.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	1206.9	288.3	243	205.3	167.3	134.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	793.7	235.9	235.9	436.1	436.1	436.1	546.2	531.4	296.7	288.1	282.3	401.8	567.8	372.3	372.3	371.7	371.4	370.1	159.8	149.7	133.4	122.6	111.4	167.7	173.2	171.4	151	157.8	17.5	13.9	11.3
balance-sheet.row.total-stockholders-equity	24465.32	6222.7	5511.9	5060	4390.7	3768	3344.3	3050	2616.5	2416.7	2305.9	1792.3	1351.1	793.4	790.3	771.6	742.7	713.6	417	372.3	334	305.6	271.4	247.1	313.7	306.2	247.2	221.5	50.1	47.8	35.3
balance-sheet.row.total-liabilities-and-stockholders-equity	51538.48	12767.7	12016.6	9163.3	7494.8	6522.6	5750.8	5691.1	5619	5394.9	5061.8	4662.3	4107.2	2061.8	1844.6	1749.7	1741.1	1614.1	1284.4	1144.9	1114.5	863.1	689.3	587.4	546.6	520.3	475.2	317.2	164.4	146.3	141.5
balance-sheet.row.minority-interest	30.39	7.7	7.3	0	0	0	0	0	0	0.1	0	65.5	14.4	13.3	18.3	23.2	25.4	36.5	38.8	39.6	37.1	23.3	15	12.6	1.4	1.7	0.8	0	0	0	0
balance-sheet.row.total-equity	24495.71	6230.4	5519.2	5060	4390.7	3768	3344.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	51538.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	650.66	174	91.4	81.2	121.7	122.2	100.9	36	32	29.6	0.5	0.5	0.5	0.5	0.5	0	0	0	23.3	27.3	31.2	91.7	99.2	105.2	99	4.9	13.3	0	0	0	0
balance-sheet.row.total-debt	6262.49	3426.7	837.3	474.3	330.3	50	614.1	1088	1296.1	1229.8	930.8	1372.9	1280.1	590	495.7	420.2	530.2	459.2	513.1	473.2	492.2	313.2	264.7	194.2	117	86	34	20	36	35.4	55.4
balance-sheet.row.net-debt	-8550.35	-154	-2715.6	-2135.7	-1864	-985.8	-29.9	541	743.1	434.7	123	562.2	448.6	338	218.5	171.9	250.1	-43.1	265.2	335.3	271.5	181.6	234.3	176.9	103.4	12.6	10.9	12.2	31	29.9	49.5

现金流量表

在 Apeloa Pharmaceutical Co.,Ltd 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.509 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 130.17. 公司的投资活动产生了现金使用净额，按报告货币计算达到-676422944.000. 与上一年相比， 0.144 发生了变化. 在同一时期，公司记录了 558.97, 0 和 -96.52，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-347.29 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 141.95，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1059.75	1055.3	989.2	955.6	816.7	553.4	370.6	256.6	262.9	208.2	326.7	161	134.6	3.2	20	32.9	26	27.8	51.1	46.1	37.5	36.7	34	-26	7.5	7.6	25.7
cash-flows.row.depreciation-and-amortization	-0.82	559	389.4	358.6	353.8	353.5	329.4	331.6	302	286.2	247.8	227.5	193.3	100.5	90.1	82.3	66.4	52.4	53.1	44.4	37.7	33.5	27.3	4.1	6.1	6.1	4.5
cash-flows.row.deferred-income-tax	0	3.6	-104	-14	18.4	-7.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-1932.7	104	14	-18.4	7.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-908.1	-777.9	-165.8	-682.1	-74.1	360.7	40.7	-482.6	-433.5	-144.8	193	-293.4	-84.6	44.2	-13.3	55.6	-39.9	57	7.7	-33.2	-49.3	13.7	-84.3	12.6	-1.5	-40.3	-2.4
cash-flows.row.account-receivables	-571.63	-571.6	-1108.1	-851.4	-176.8	-294.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-373.35	-373.3	-603.1	-190.1	-116.9	-124.9	-207.5	-60.2	6	-168.8	29.4	-163.2	2.4	-43.1	-39.3	37	-69.8	-10.5	-15.2	-8	-22.2	-7.9	-56.1	22	13.4	-3.3	-15.8
cash-flows.row.account-payables	0	130.2	1649.3	373.4	201.1	787.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	36.87	36.9	-104	-14	18.4	-7.8	248.2	-422.3	-439.5	24	163.6	-130.1	-87	87.3	26	18.6	29.9	67.5	22.9	-25.2	-27	21.5	-28.2	-9.4	-14.9	-37	13.4
cash-flows.row.other-non-cash-items	937.72	2124.1	113.3	-20.3	-36.9	92.4	92	104.2	49	91.5	19.2	95.3	92.7	33.8	24.2	37.5	42.1	37	47.5	30.1	21.6	21.5	25.8	8.7	-5.1	6	2.2
cash-flows.row.net-cash-provided-by-operating-activities	1088.54	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-634.54	-630.5	-509.1	-701.9	-317.1	-31.8	-81.6	-163.4	-331.4	-452.1	-540.2	-505	-339.6	-289.2	-139.8	-93.7	-349	-115.7	-53.8	-121.7	-111.1	-88.1	-47.2	-1	-3.2	-7.8	-16.4
cash-flows.row.acquisitions-net	46.96	39.7	12.2	3.9	16.7	-1	16.3	246.7	14.5	11.8	22.9	-1.6	352	0	5	0	0	-4.3	0	0	1.9	0	0	0	3.2	7.8	0
cash-flows.row.purchases-of-investments	-161.37	-172.9	-389	-446.9	-424.5	-864	-356.5	-196.9	-34	-48.5	34.9	-8.4	-0.5	0	-52.8	0	0	0	0	0	-28.2	0	0	0	-92.9	-3	0
cash-flows.row.sales-maturities-of-investments	87.26	87.3	383.2	559.1	821.8	516.9	257.1	197.6	34.2	47.8	11	1	0.6	0	50	0	0	0	0	0	61.1	0	0	6.3	4.2	11.4	0
cash-flows.row.other-investing-activites	-8.73	0	-88.6	70.5	9.5	-60.9	-14.3	-163.4	16.9	0	-0.2	9.9	-339.6	28.3	1.1	1	1.2	4.1	1.7	4.4	11.9	35.4	11.6	8.1	-3.2	-7.8	0
cash-flows.row.net-cash-used-for-investing-activites	-670.42	-676.4	-591.3	-515.4	106.4	-440.8	-179	-79.4	-299.8	-441	-471.6	-504.1	-327.1	-261	-136.5	-92.7	-347.9	-116	-52.1	-117.3	-64.4	-52.7	-35.6	13.4	-91.9	0.6	-16.4
cash-flows.row.debt-repayment	-814.12	-96.5	-712.7	-698.2	-204	-944.1	-1639	-1675.5	-1454.8	-1081.4	-1880.5	-1368.8	-1901.1	-675	-634.6	-500	-281	-391.9	-101	-59	-290.5	-271	-199.6	-75.8	-79.8	-38.2	-13
cash-flows.row.common-stock-issued	0	0	200.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	-200.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-386.19	-347.3	-362.8	-301.9	-201.4	-142.1	-119.8	-141.6	-129.4	-162.5	-88.2	-75.4	-84.7	-40.2	-31.2	-37.4	-39.9	-44.7	-39.4	-30.6	-24.5	-18.3	-24.6	-10.3	-6	-1.8	-12.4
cash-flows.row.other-financing-activites	913.9	141.9	879.4	795.8	484.1	380	1165.1	1724.6	1631.5	1286.6	1644.8	1821.4	2031.8	769.3	710.1	390	352	632.8	143	36.7	421.1	337.8	270.1	77	110.9	110.2	27
cash-flows.row.net-cash-used-provided-by-financing-activities	-366.84	-301.9	-196.1	-204.3	78.7	-706.2	-593.7	-92.5	47.3	42.6	-323.8	377.2	46.1	54.1	44.3	-147.4	31.1	196.2	2.6	-52.9	106.1	48.5	45.9	-9.1	25	70.2	1.6
cash-flows.row.effect-of-forex-changes-on-cash	39.7	27.5	44	-17.3	-38.3	3.3	7.3	-14.4	18.4	10.1	-0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-0.36	27.8	582.8	-125.3	1206.4	216.4	67.2	23.4	-53.6	52.9	-9.6	63.5	54.9	-25.2	28.9	-31.8	-222.2	254.5	109.9	-82.8	89.2	101.1	13.1	3.7	-59.8	50.3	15.3
cash-flows.row.cash-at-end-of-period	11369.38	3580.7	2381.9	1799.2	1924.4	718.1	501.4	434.1	410.7	464.4	411.5	421.1	357.5	252.1	277.2	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1
cash-flows.row.cash-at-beginning-of-period	11369.75	3552.9	1799.2	1924.4	718.1	501.7	434.1	410.7	464.4	411.5	421.1	357.5	302.6	277.2	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1	7.8
cash-flows.row.operating-cash-flow	1088.54	1031.4	1326.1	611.7	1059.5	1360.1	832.7	209.8	180.4	441.2	786.6	190.4	335.9	181.7	121	208.3	94.6	174.2	159.4	87.4	47.5	105.4	2.8	-0.6	7.1	-20.5	30.1
cash-flows.row.capital-expenditure	-634.54	-630.5	-509.1	-701.9	-317.1	-31.8	-81.6	-163.4	-331.4	-452.1	-540.2	-505	-339.6	-289.2	-139.8	-93.7	-349	-115.7	-53.8	-121.7	-111.1	-88.1	-47.2	-1	-3.2	-7.8	-16.4
cash-flows.row.free-cash-flow	454	400.9	817	-90.2	742.4	1328.2	751.1	46.4	-150.9	-10.9	246.4	-314.6	-3.7	-107.5	-18.8	114.6	-254.5	58.5	105.6	-34.3	-63.5	17.3	-44.4	-1.6	3.9	-28.3	13.7

利润表行

Apeloa Pharmaceutical Co.,Ltd 的收入与上期相比变化了 0.083%。据报告, 000739.SZ 的毛利润为 2731.52。该公司的营业费用为 1649.39，与上年相比变化了 13.274%. 折旧和摊销费用为 558.97，与上一会计期间相比变化了 0.020%. 营业费用报告为 1649.39，显示13.274% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.070%. 营业收入为 1082.12，与上年相比变化了0.070%. 净利润的变化率为 0.067%。去年的净收入为1055.34.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	11567.99	11418.1	10544.9	8942.6	7879.7	7210.7	6376.4	5551.8	4772.2	4337.9	4232.8	3899.8	3480.1	1534.5	1521	1367.9	1250.4	1041.5	1148.6	1035.4	830.5	770.3	659.3	141.8	178.8	225.6	418.1	367.7	368.7	344.3	331.2
income-statement-row.row.cost-of-revenue	8770.97	8686.6	8024.2	6569.3	5676.6	4876.6	4340.5	3839.9	3444.3	3149.7	3131.4	3017	2672.7	1236.9	1201.1	1068.9	1011.5	845.8	915.4	833.4	671.4	611.2	511	130.7	156.6	187.1	366.3	313.1	313.6	294.6	288
income-statement-row.row.gross-profit	2797.01	2731.5	2520.7	2373.3	2203	2334.1	2035.9	1711.9	1327.9	1188.2	1101.4	882.8	807.4	297.6	319.9	298.9	238.9	195.7	233.1	202	159.1	159	148.3	11.1	22.3	38.5	51.8	54.6	55	49.7	43.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	557.97	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	64.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	676.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-39.69	-42	313.2	264.7	216.9	269.6	-30.8	3.9	74.4	66.8	28.7	22.7	27.1	16.1	7.2	3.9	1.2	6.6	2.5	1.7	1.5	0.7	2.4	7.5	16.7	13.9	19.8	7.1	5.8	6.4	4.1
income-statement-row.row.operating-expenses	1686	1649.4	1456.1	1287.3	1251.2	1608.4	1516.6	1255.7	1015.5	913.4	744.9	634.9	550.1	252.7	250.4	218	173.5	132.6	139.1	125.2	90.2	90.5	78.5	32.7	36	39.8	35.4	29.4	35.8	33.5	31.3
income-statement-row.row.cost-and-expenses	10456.97	10336	9480.3	7856.7	6927.9	6484.9	5857.1	5095.6	4459.8	4063.1	3876.3	3651.9	3222.9	1489.6	1451.5	1286.9	1185	978.5	1054.6	958.6	761.6	701.8	589.5	163.4	192.5	226.9	401.7	342.5	349.4	328.1	319.4
income-statement-row.row.interest-income	-22.64	113.6	75.8	75.3	24.9	7.3	5.4	4.2	8.9	12.2	19.3	17.2	11.2	3.6	2.9	4.8	6.8	3.2	4	1.3	1	1.9	1.9	0.1	0.9	0	0	0	0	0	0
income-statement-row.row.interest-expense	34.1	47.2	59.2	35.7	16	30.2	42	62.1	62.3	66.1	80.2	82.1	107.6	40.4	37.7	36.2	34.8	37.6	33.7	23.7	17.8	13.5	16.4	8.6	6.3	2.8	1.6	0.8	5.1	4.4	2
income-statement-row.row.selling-and-marketing-expenses	676.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	66.36	119.3	0.4	-5.3	-8.6	-10.4	-57.1	-116.5	22.9	-27.8	20.7	-42.2	-88.9	-41.1	-42.1	-43.2	-38	-31.8	-35.9	-28.4	-21.7	-19.7	-19.9	-11.9	4.2	-1.8	2.4	3.7	-5.1	-4.5	-2.2
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-39.69	-42	313.2	264.7	216.9	269.6	-30.8	3.9	74.4	66.8	28.7	22.7	27.1	16.1	7.2	3.9	1.2	6.6	2.5	1.7	1.5	0.7	2.4	7.5	16.7	13.9	19.8	7.1	5.8	6.4	4.1
income-statement-row.row.total-operating-expenses	66.36	119.3	0.4	-5.3	-8.6	-10.4	-57.1	-116.5	22.9	-27.8	20.7	-42.2	-88.9	-41.1	-42.1	-43.2	-38	-31.8	-35.9	-28.4	-21.7	-19.7	-19.9	-11.9	4.2	-1.8	2.4	3.7	-5.1	-4.5	-2.2
income-statement-row.row.interest-expense	34.1	47.2	59.2	35.7	16	30.2	42	62.1	62.3	66.1	80.2	82.1	107.6	40.4	37.7	36.2	34.8	37.6	33.7	23.7	17.8	13.5	16.4	8.6	6.3	2.8	1.6	0.8	5.1	4.4	2
income-statement-row.row.depreciation-and-amortization	238.89	559	548	460.3	338.9	407.6	329.4	331.6	302	286.2	247.8	227.5	193.3	100.5	90.1	82.3	66.4	52.4	53.1	44.4	37.7	33.5	27.3	4.1	6.1	6.1	4.5	-5.9	-0.7	-2.1	-2.3
income-statement-row.row.ebitda-caps	1379.21	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1140.32	1082.1	1011.6	1119.4	969.7	644.2	490.5	335.7	273.6	202.3	343.1	185.5	143.6	-11.4	21.2	34.6	26.7	25.4	61.4	52.9	48.6	50.7	49.9	-25	4.9	8.9	30.6	31.1	20	18.3	14.1
income-statement-row.row.income-before-tax	1206.68	1201.4	1012.1	1114.1	961.2	633.7	462.2	339.6	335.3	247	377.2	205.7	168.3	3.8	27.3	37.8	27.4	31.3	61	51.5	48.7	50.1	51.1	-25.5	6	9.9	34.6	33.5	20	18.2	13.9
income-statement-row.row.income-tax-expense	149.86	149.3	22.9	158.5	144.4	80.3	91.6	83	72.4	38.8	50.5	44.8	33.7	0.6	7.3	4.9	1.4	3.4	9.8	5.4	11.2	13.4	17.2	0.5	-1.5	2	8.5	10.5	5.7	5.2	3.4
income-statement-row.row.net-income	1059.75	1055.3	989.2	955.6	816.7	553.4	370.6	256.6	262.9	208.2	322.2	167.4	137.1	8.2	23.8	34.1	29.1	30.4	52	43.8	35.6	34.2	31.6	-25.9	7.5	7.6	25.7	23	14.2	13	10.6